(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Related Articles
Research
Wedbush Initiates Hemab Therapeutics at Outperform With $42 Price Target
$COAG
Research
Goldman Sachs Downgrades Futu Holdings to Neutral From Buy, Adjusts Price Target to $102.13 From $210.47
Futu Holdings (FUTU) has an average rating of buy and mean price target of $192.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$FUTU
Research
Itau BBA Upgrades Ternium S.A to Outperform From Market Perform, Adjusts PT to $59 From $39
$TX